CRADD antibody Usage And Synthesis

Applications

CRADD antibody has been tested by ELISA, Western blot and ICC/IF analysis to assure specificity and reactivity.

Immunogen

Anti-human CRADD mAb, is derived from hybridization of mouse F0 myeloma cells with spleen cells from BALB/c mice immunized with a recombinant human CRADD protein 1-199 amino acids purified from E. coli.

Background

CRADD is a 22kDa, widely-expressed cytosolic adaptor/signaling protein that induces cell apoptosis/cell death in numerous tissues. CRADD is a death domain (CARD) that recruits, caspase 2/ICH1 to the cell death signal transduction complex that includes TNFR1A, RIPK1/RIP kinase, and numbers of other CARD domain-containing proteins.

CRADD antibody()Related Product Information

• eIF3H antibody
• RRBP1 antibody
• HYAL2 antibody
• KARS1 antibody
• RIPK1 antibody
• P3H3 antibody
• DLD antibody
• BUB3 ANTIBODY
• PDLIM7 antibody
• TAB3 Antibody